Clinical Trials Browser

Phase 2 × Valacyclovir × Lymphoid × Clear all

NCT00492050 2026-03-11

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Phase 2 Active not recruiting

46 enrolled 10 charts

Waldenstrom Macroglobulinemia

NCT00562770 2012-07-31

Oral Valganciclovir Versus Valacyclovir

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell